Hutch News

Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium

Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium

Event draws leading researchers in transplantation, gene and cell therapy
Hutch NewsOctober 07, 2022
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell

What's next for T-cell therapies: Q&A with Dr. Stanley Riddell

After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Hutch NewsFebruary 05, 2021
Fred Hutch Evergreen Fund awards six grants to promising projects

Fred Hutch Evergreen Fund awards six grants to promising projects

Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Hutch NewsSeptember 22, 2020
Immunotherapy prevents relapse in small leukemia trial

Immunotherapy prevents relapse in small leukemia trial

Engineered T cells kept leukemia from returning in 12 high-risk patients
Hutch NewsJune 24, 2019
Learning more from T-cell therapy trials

Learning more from T-cell therapy trials

Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle
Hutch NewsMarch 28, 2018
New insights into CAR T-cell therapy's potential side effects

New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer
Hutch NewsDecember 11, 2017